Form 4 Tracker
Evolent Health, Inc.
EVH

19 insider filings · Latest: Aug 26, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Aug 26, 2026Aug 28 8:17 PMDaniel Joseph MccarthyPRESIDENT
Sale
65,892$5.00$329.5K655,133(D)

View →

Aug 26, 2026Aug 26 9:42 PMDaniel McCarthy
Proposed Sale
65,892$4.97$327.5K—

View →

Feb 25, 2025Feb 25 9:47 PMDUFFY MARY BRIDGET
Proposed Sale
9,151$10.27$93.9K—

View →

Aug 22, 2024Aug 23 7:48 PMMcCarthy Daniel Joseph
Proposed Sale
34,162$32.63$1.1M—

View →

Aug 22, 2024Aug 22 8:03 PMWeinberg Jonathan
Proposed Sale
42,140$31.17$1.3M—

View →

Aug 22, 2024Aug 22 8:01 PMBlackley Seth
Proposed Sale
187,904$29.97$5.6M—

View →

Aug 22, 2024Aug 22 8:00 PMRafferty Emily Ann
Proposed Sale
8,861$29.97$265.6K—

View →

Aug 22, 2024Aug 22 7:59 PMJohnson John Paul
Proposed Sale
44,693$29.97$1.3M—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 2, 2026Mar 4 11:02 PMSeth BlackleyDirector, Chief Executive Officer
Grant/Award
1,425,310—1,425,310(D)

View →

Mar 2, 2026Mar 4 10:58 PMJonathan WeinbergGeneral Counsel
Grant/Award
179,661—179,661(D)

View →

Mar 2, 2026Mar 4 10:53 PMDaniel Joseph MccarthyPRESIDENT
Grant/Award
826,440—826,440(D)

View →

Mar 2, 2026Mar 4 10:48 PMAammaad ShamsChief Accounting Officer
Grant/Award
55,173—55,173(D)

View →

Mar 2, 2026Mar 4 10:43 PMMario RamosChief Financial Officer
Grant/Award
429,041—429,041(D)

View →